News

#27 Jamie Simpson | The U.S. policy perspective on SEPs

Apple Keeps Chasing the Ultimate Health-Tracking Watch—but It Could Take Years

The Top U.S. FRAND / RAND Licensing Developments of 2023 Part II: Ghosts of Christmas Past and Christmas Future

From AI to Amgen, Here’s Everything IP that Mattered in 2023

Gov. Hochul expected to veto N.Y. ban on noncompete agreements

Why the Apple Watch is being banned — and how Apple can avoid it

How to avoid fake products when shopping online

Biden Drug Patent Seizures Would Test Scope of Government Power

Proposed Framework on March-In Rights Dubbed ‘Unprecedented’ by U.S. Chamber

‘Oh when the government goes marching in’ a rising US threat?

Biden proposal on ‘march in’ rights would have limited effect on current drug costs, critics say

Ex-USPTO Directors Rally Against WTO IP Waiver

Scroll to Top